PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
09-Feb-2023 Biotest AG: Biotest significantly exceeds EBIT guidance 2022 Biotest AG
09-Feb-2023 Molecular Diagnostics for Cancer Markets Report 2023: The Emergence of New Economies with Large Markets - ResearchAndMarkets.com Businesswire
09-Feb-2023 Takeda schließt Übernahme der TYK2-Programm-Tochter von Nimbus Therapeutics ab Businesswire
09-Feb-2023 Global KRAS Inhibitors Market Report to 2029: Featuring Ascentage Pharma, AstraZeneca, Boehringer Ingelheim and BridgeBio Pharma Among Others - ResearchAndMarkets.com Businesswire
09-Feb-2023 Insights on the Smart Packaging Global Market to 2027 - by Technology, End-user and Region - ResearchAndMarkets.com Businesswire
09-Feb-2023 Astex and Cardiff University Medicines Discovery Institute Announce New Drug Discovery Collaboration on Neurodegenerative Diseases Astex
09-Feb-2023 NRG Therapeutics Appoints Gilles Ouvry Ph.D. as Vice President of Chemistry to Advance its Mitochondrial Therapeutics for Neurodegenerative Disorders NRG Therapeutics
09-Feb-2023 BSI LIFE SCIENCES AND LEDGER RUN PARTNER TO STREAMLINE CLINICAL BUSINESS OPERATIONS BSI Life Sciences & Ledger Run
09-Feb-2023 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
09-Feb-2023 Global Cannabis Use Disorder Treatment Market to reach US$ 2.66 billion by 2033, 67% of Treatment to be for Tobacco/Nicotine and Vaping De-addiction MARKITWIRED
09-Feb-2023 Chloangiocarcinoma (CCA) Therapeutics Market to Register 2% CAGR in the Forecast Period 2023-2033: FMI Study MARKITWIRED
09-Feb-2023 Celyad Oncology Announces the Publication of Data From Its Phase 1 THINK Study of CYAD-01 Businesswire
09-Feb-2023 SeqOne Genomics and the French Thrombotic MicroAngiopathies National Reference Center (CNR-MAT) Pioneer the Use of Oxford Nanopore Sequencing Technology to Improve Patient Outcomes in Kidney Disease While Reducing Turnaround Times Businesswire
09-Feb-2023 Takeda finalise l’acquisition de la filiale de Nimbus Therapeutics consacrée au programme TYK2 Businesswire
09-Feb-2023 Takeda finaliza la adquisición de la filial del programa TYK2 de Nimbus Therapeutics Businesswire
09-Feb-2023 Dystrophic Epidermolysis Bullosa Management Market to reach US$ 787.8 Million by 2033, Antibiotics to Constitute 32% of all Treatments | FMI Study MARKITWIRED
09-Feb-2023 Adoption of New Assays and Launch of Combination Drugs Will Propel Growth of Complicated Urinary Tract Infections Treatment Market | FMI Study MARKITWIRED
09-Feb-2023 The Global Encephalitis Treatment Market Is Expected to Register Growth at 5.4% CAGR through 2033 | FMI Study MARKITWIRED
09-Feb-2023 From 2023 through 2033, Cancer Biopsy sales to expand at a CAGR of over 18%, Reveals Future Market Insights MARKITWIRED
09-Feb-2023 Global Hyperpigmentation Treatment market to exhibit a CAGR of 7.4% until 2033, reaching US$ 11.84 billion: FMI Study MARKITWIRED